The Global Health Program, founded by Bill and Melinda Gates, scheduled to commence in June, has acquired a new Executive Director, according to the Gates foundation Release. Dr Tadataka Yamada, Chair of Research and Development at GlaxoSmithKline, will now lead the program.
Yamada's key portfolio will focus on driving the foundation's Vaccination Initiatives while also working on enhancing the availability of drugs to fight diseases such as Aids, tuberculosis and Malaria, in the developing countries.
Advertisement
Bill Gates, co-chair of the foundation, said, "Melinda and I are thrilled to have someone with Dr. Yamada's breadth of experience leading the foundation's work on global health," adding, 'He's organized the best talent around big challenges, knows what it takes to bring promising science from the lab to people in need and understands how to engage new partners'
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.